企業プロフィール
Agenus 株価・ニュース・カタリスト
- ティッカー:
- AGEN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
7.67 USD (-5.19%)
終値
最終更新: 2026年8月24日
141M USD
時価総額
株価変動の要因
As of Aug 24, 2026, AGEN closed down 5.19% at $7.67. No new same-company headline was identified in the current news window.
企業概要
事業概要
Agenus is an immuno-oncology company focused on cancer immunotherapy, including checkpoint and combination approaches. The company has spent years trying to turn immune science into a durable oncology franchise.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Agenus sits in specialty oncology biotechnology.
ビジネスモデルの特徴
The business depends on clinical data, strategic partnerships, and the ability to translate immunotherapy science into value.
バイオ業界での位置付け
Agenus is a high-risk oncology name whose valuation is heavily dependent on clinical and strategic milestones.
今後のカタリスト
- Agenus's catalysts are botensilimab and balstilimab combination data, plus any partnering progression that can de-risk the program. The company still needs proof that the immuno-oncology story can keep moving.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。